The frequency of CD103+ cross‐presenting DCs increased twofold under these conditions (Figure 5d), suggesting that these DCs captured antigens at the tumor site and migrated to the TDLN to activate NK and T cells. This evidence concerns the gene ITGAE and neoplasm.